Drawing for MYOGUIDE

USPTO serial 86825875

MYOGUIDE

Reviewed by CopyMark Law Group

Reg. 5283472Status 701Renewal
Filing date
Status date
Registration date
Sep 12, 2017
Examiner
MAYES, LAURIE ANN
Law office
TMEG LAW OFFICE 101

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 701: Status 701 means the registration is active and the first Section 8 declaration of continued use was accepted. The next major deadline is the combined Section 8 and Section 9 filing at the 10-year anniversary.

Need help with MYOGUIDE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*

Plus Government fees of $1,300

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jeremy Peter Green Eche

Jeremy Peter Green Eche JPG Legal163 23rd StGround FloorBrooklyn, NY 11232

Goods and services

ClassDescriptionStatusFirst use
009Computer software system primarily comprised of software for connecting and synchronizing video with biological signal data collected, and integrating into a patient's electronic medical record (EMR) for use in the medical field and is specifically designed for creating electronic medical records (EMR) related to the management of pain and spasticity and allows the creation of an electronic medical record (EMR), which includes and tracks biometric data, injection documentation, spasticity and pain index tracking, billing documentation, and report generation for use in the medical field; computer software system primarily comprised of software for providing a collection of video and E-learning applications presenting educational material to clinicians for integration into software, stand alone, or web based applications, including various topics of anatomy review, muscle activation, instructional review, and device operating instructions for use in the medical field; computer software system, namely, a motion tracking system primarily comprised of software for monitoring body movement that can be used in applications where freedom of movement is required and may be comprised of video or accelerometer based tracking devices that will not load limbs being monitored for movement all for use in the medical fieldACTIVE—
010A handheld electromyographic medical device with signal display and stimulator, namely, used for muscle and nerve localizations as well as an aid for guidance of injections into the muscles of the body for use in the medical field; a handheld electromyographic medical device with signal display, namely, a multifunction stimulator and electromyogram (EMG) amplifier used for electromyogram EMG studies, nerve conduction studies, electrodiagnostic functions, namely, multi-channel electroencephalography studies, multi-channel sleep studies, multi-channel biosignal measurements with or without motion tracking and can be used to measure, display, store, retrieve and analyze muscle signal measurements for research purposes, synchronize video motion tracking to the collected data, and used to generate colour coded topographical maps depicting the electrical energy generated by the areas being measured for use in the medical field; a portable and wireless multi-channel biological amplifier, namely, designed to be able to carry out surface electromyography (sEMG) as well as electroencephalography (EEG) for a number of medical applications for use in the medical fieldACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 12, 2026REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Apr 27, 2023NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED—
Apr 27, 20238.OKREGISTERED - SEC. 8 (6-YR) ACCEPTEDThe USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline.
Apr 27, 2023APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Sep 26, 2022ES8RTEAS SECTION 8 RECEIVED—
Sep 12, 2022REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Sep 12, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 27, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 27, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 7, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 23, 2017PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
May 15, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 15, 2017XAECEXAMINER'S AMENDMENT ENTERED—
May 13, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 13, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
May 13, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
May 12, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 12, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 3, 2017ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Nov 5, 2016GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Nov 5, 2016GNSLLETTER OF SUSPENSION E-MAILED—
Nov 5, 2016CNSLSUSPENSION LETTER WRITTEN—
Nov 2, 2016XAECEXAMINER'S AMENDMENT ENTERED—
Nov 1, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 1, 2016GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 1, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 19, 2016GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Oct 19, 2016GNSLLETTER OF SUSPENSION E-MAILED—
Oct 19, 2016CNSLSUSPENSION LETTER WRITTEN—
Oct 19, 2016XAECEXAMINER'S AMENDMENT ENTERED—
Oct 19, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 19, 2016GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 19, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 29, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 29, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 24, 2016ALIEASSIGNED TO LIE—
Sep 14, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 18, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 18, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 18, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 11, 2016DOCKASSIGNED TO EXAMINER—
Nov 24, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 23, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance